Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Psoriasis, Date of authorisation: 25/04/2016, Revision: 7, Status: Authorised
One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage PlusPublished in last 50 years